Literature DB >> 30672819

Sedatives in neurocritical care: an update on pharmacological agents and modes of sedation.

Olivier Opdenakker1, Anna Vanstraelen1,2, Veerle De Sloovere2, Geert Meyfroidt1,3.   

Abstract

PURPOSE OF REVIEW: In this article, the specific and general indications for sedatives in the neurocritical care unit are discussed, together with an overview on current insights in sedative protocols for these patients. In addition, physiological effects of sedative agents on the central nervous system are reviewed. RECENT
FINDINGS: In the general ICU population, a large body of evidence supports light protocolized sedation over indiscriminate deep sedation. Unfortunately, in patients with severe acute brain injury, the evidence from randomized controlled trials is scarce to nonexistent, and practice is supported by expert opinion, physiological studies and observational or small interventional trials. The different sedatives each have different beneficial effects and side-effects.
SUMMARY: Extrapolating the findings from studies in the general ICU population suggests to reserve deep continuous sedation in the neuro-ICU for specific indications. Although an improved understanding of cerebral physiological changes in patients with brain injury may be helpful to guide individualized sedation, we still lack the evidence base to make broad recommendations for specific patient groups.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 30672819     DOI: 10.1097/MCC.0000000000000592

Source DB:  PubMed          Journal:  Curr Opin Crit Care        ISSN: 1070-5295            Impact factor:   3.687


  5 in total

1.  A gap existed between physicians' perceptions and performance of pain, agitation-sedation and delirium assessments in Chinese intensive care units.

Authors:  Linlin Zhang; Jian-Xin Zhou; Kai Chen; Yan-Lin Yang; Hong-Liang Li; Dan Xiao; Yang Wang
Journal:  BMC Anesthesiol       Date:  2021-02-25       Impact factor: 2.217

2.  Ketamine in acute phase of severe traumatic brain injury "an old drug for new uses?"

Authors:  Daniel Agustin Godoy; Rafael Badenes; Paolo Pelosi; Chiara Robba
Journal:  Crit Care       Date:  2021-01-06       Impact factor: 9.097

Review 3.  Brain-lung interactions and mechanical ventilation in patients with isolated brain injury.

Authors:  Mairi Ziaka; Aristomenis Exadaktylos
Journal:  Crit Care       Date:  2021-10-13       Impact factor: 9.097

Review 4.  ARDS associated acute brain injury: from the lung to the brain.

Authors:  Mairi Ziaka; Aristomenis Exadaktylos
Journal:  Eur J Med Res       Date:  2022-08-13       Impact factor: 4.981

Review 5.  Ketamine in Acute Brain Injury: Current Opinion Following Cerebral Circulation and Electrical Activity.

Authors:  Christian Zanza; Fabio Piccolella; Fabrizio Racca; Tatsiana Romenskaya; Yaroslava Longhitano; Francesco Franceschi; Gabriele Savioli; Giuseppe Bertozzi; Stefania De Simone; Luigi Cipolloni; Raffaele La Russa
Journal:  Healthcare (Basel)       Date:  2022-03-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.